top of page

CELL THERAPY

  • Genetically engineered cell therapies, such as CAR-T and TCR cells, demonstrate outstanding efficacy in treatment of cancer
     

  • A new generation of cell products offers off-the-shelf stem cells for regenerative use in therapeutic areas with high unmet medical needs 

THERAPEUTIC AREAS

  • Haematological malignancies

  • Inflammatory and auto-immune disorders

  • Disorders of the HSC lineage

Invest_europe.png
4BIO Capital is a trading name of 4BIO Partners LLP which is authorised and regulated by the Financial Conduct Authority (Reference Number 842764)

4BIO Partners LLP is an SEC Registered Investment Advisor number 801-121342
© 2015-2024 by 4BIO Partners LLP
bottom of page